| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 02/28/2008 | US20080050784 Ability to produce L-glutamic acid, valine, threaonine, histidine or proline is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 02/27/2008 | EP1890711A1 Compounds for treating or preventing amine oxidase related diseases or disorders |
| 02/27/2008 | EP1670897A4 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 02/27/2008 | EP1601765B1 Variants of enzymes of the alpha-amylase family |
| 02/27/2008 | CN101130778A Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
| 02/26/2008 | US7335476 Expression vector comprising nucleotide sequences coding desaturase for use in transformation of yeast and propagation of eicosapentaenoic, gamma-linoleic and stearidonic acids; bioreactors |
| 02/26/2008 | US7335347 Methods for purifying radiolabelled compounds |
| 02/26/2008 | US7335153 Arrays of microparticles and methods of preparation thereof |
| 02/21/2008 | US20080044520 Phytase active yeast |
| 02/20/2008 | CN101128475A Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 02/19/2008 | US7332645 IL-21 as a regulator of immunoglobin production |
| 02/19/2008 | US7332582 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject |
| 02/14/2008 | WO2005001065A3 Variant humicola grisea cbh1.1 |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039382 Compositions related to pleiotrophin methods and uses thereof |
| 02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
| 02/14/2008 | US20080038232 Production of high mannose proteins in plant culture |
| 02/13/2008 | EP1885848A1 Microbial conversion of sugar acids and means useful therein |
| 02/13/2008 | EP1885742A1 Compositions for targeting amine oxidases in vivo |
| 02/13/2008 | EP1631659A4 Modulation of the rna interference pathway |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | CN101124240A Specific binding agents to hepatocyte growth factor |
| 02/12/2008 | US7329799 Expresion vector comprising nucleotide sequences coding enzyme inhibitors for use as tool in increasing yield and oil production in corn |
| 02/12/2008 | US7329762 Prodrugs of mitotic kinesin inhibitors |
| 02/12/2008 | US7329222 Comparative field analysis (CoMFA) utilizing topomeric alignment of molecular fragments |
| 02/07/2008 | US20080032418 Cell Free Assay Systems For Identifying A Substance Of Interest |
| 02/07/2008 | US20080032286 Competition Assay for Identifying Modulators of Quadruplex Nucleic Acids |
| 02/06/2008 | CN101120083A Cell culture methods and devices utilizing gas permeable materials |
| 02/06/2008 | CN101116746A Prevention and treatment of amyloidogenic disease |
| 02/05/2008 | US7326771 Fluorescent proteins from coelentrates (Corynactis californica), genes encoding the proteins and variants, having unique absorption and emission spectra |
| 02/05/2008 | US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis |
| 02/05/2008 | CA2223821C Magnetic particles with a glass surface and their use |
| 01/31/2008 | WO2005056766A3 TARGETED DRUG DELIVERY USING EphA2 OR Eph4 BINDING MOIETIES |
| 01/31/2008 | US20080028482 Corn Plant Mon88017 and Compositions and Methods for Detection Thereof |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080026407 Covalent tethering of functional groups to proteins |
| 01/31/2008 | US20080026064 Cell-polymer fiber compositions and uses thereof |
| 01/31/2008 | US20080025980 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject; HIV infection or AIDS (Acquired Immune Deficiency Syndrome) |
| 01/30/2008 | EP1687450A4 Real-time detection of nucleic acids and proteins |
| 01/30/2008 | EP1620722A4 Methods for characterizing signaling pathways and compounds that interact therewith |
| 01/30/2008 | CN101113450A Neurotrophic factor |
| 01/30/2008 | CN101113449A Neurotrophic factor |
| 01/30/2008 | CN101112616A Vaccine for the prophylactic or therapeutic immunization against HIV |
| 01/29/2008 | US7323553 Non-affinity purification of proteins |
| 01/29/2008 | US7323496 Compounds for treatment of inflammation, diabetes and related disorders |
| 01/29/2008 | US7323320 In situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, "on device" assembly of larger polynucleotides composed of shorter oligonucleotide fragments |
| 01/24/2008 | WO2004081188A3 Non-toxic membrane-translocating peptides |
| 01/24/2008 | US20080021082 Small molecule inhibition of a PDZ-domain interaction |
| 01/24/2008 | US20080020397 Optimization of crossover points for directed evolution |
| 01/24/2008 | US20080019953 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 01/23/2008 | EP1668361A4 Cell-based assays for determining drug action |
| 01/23/2008 | EP1656012A4 Plants resistant to cytoplasm-feeding parasites |
| 01/23/2008 | EP1627044A4 Methods, systems and apparatus for identifying genetic differences in disease and drug response |
| 01/23/2008 | EP1622635A4 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 01/23/2008 | EP1410301A4 System for identifying and analyzing expression of are-containing genes |
| 01/22/2008 | US7320857 Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof |
| 01/17/2008 | WO2005037999A3 Treatment of cancer using antibodies to lrrc15 |
| 01/17/2008 | WO2005021726A3 Immunogenic hiv compositions and related methods |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | US20080015142 Glycopegylated Follicle Stimulating Hormone |
| 01/17/2008 | US20080014593 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 01/17/2008 | US20080014178 Method for Stimulating Mammalian Cells and Mammalian Cell |
| 01/16/2008 | EP0991761B1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 01/16/2008 | CN100361607C Filter containing a metal phthalocyanine and a polycationic polymer |
| 01/15/2008 | US7319021 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell |
| 01/15/2008 | US7319010 Detection and treatment of cancers of the colon |
| 01/15/2008 | US7319005 Primers and primer sets for use in methods to detect the presence of Acidovorax avenae subsp. citrulli |
| 01/15/2008 | CA2260765C Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants |
| 01/10/2008 | WO2005014797A3 P16 mediated regulation of nmda receptors |
| 01/10/2008 | US20080009454 Polynucleotide |
| 01/10/2008 | US20080008706 B7S1: an immune modulator |
| 01/09/2008 | EP1021552B1 Transgenic lemnaceae |
| 01/09/2008 | CN100360565C Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 01/08/2008 | US7316813 Influenza vaccine composition |
| 01/03/2008 | WO2005010166A3 P450 oxygenases and methods of use |
| 01/03/2008 | WO2004113506A3 A method for the development of ruminant feed formulations |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1692263A4 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis |
| 01/02/2008 | EP1660646A4 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 01/02/2008 | EP1485399A4 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS |
| 01/01/2008 | US7314925 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography |
| 01/01/2008 | US7314642 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 12/27/2007 | WO2005056765A8 Methods for culturing keratinocytes from human embryonic stem cells |
| 12/27/2007 | US20070298414 Engineering Enzymes Through Genetic Selection |
| 12/27/2007 | US20070298051 Adjuvants Of Immune Response |
| 12/27/2007 | US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury |
| 12/26/2007 | EP1696790A4 Apparatus and methods for assessing metabolic substrate utilization |
| 12/26/2007 | EP1694866A4 Gene expression profiles and methods of use |
| 12/26/2007 | EP1664283A4 Cell culture media |
| 12/26/2007 | EP1623010A4 Preservation of rna in a biological sample |
| 12/26/2007 | CN101092609A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 12/25/2007 | US7312229 21-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 12/25/2007 | US7312086 Comprises nucleotide sequences coding membrane protein for diagnosis and treatment of nervous system, cancer, kidney, reproductive, inflammatory and metabolic disorders |
| 12/25/2007 | US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 12/21/2007 | WO2004094593A3 Expanding the eukaryotic genetic code |
| 12/21/2007 | WO2004090106A3 Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design |
| 12/21/2007 | WO2004005458A3 Functional sites |
| 12/20/2007 | US20070292350 Method For Testing A Compound For A Therapeutic Effect And A Diagnostic Method |
| 12/19/2007 | EP1689887A4 Methods for quantitative determination of methylation density in a dna locus |
| 12/19/2007 | EP1682677A4 Differential enzymatic fragmentation |